Skip to main content
SpringerLink
Log in

Perioperative Management of Pulmonary Hypertension

  • Chapter
  • First Online:
Anesthesia and Perioperative Care for Organ Transplantation

  • 2284 Accesses

Abstract

The perioperative management of patients with pulmonary hypertension (PH) undergoing heart and lung transplantation is challenging. As more patients with near-systemic pulmonary pressures receive donor lungs and pulmonary pressure cutoff values for heart transplant candidates become more fluid, perioperative physicians will be required to care for an increasing number of critically ill patients. Multidisciplinary care involving anesthesiologists, intensivists, PH experts, and cardiac surgeons is pivotal for a favorable outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ramakrishna G, Sprung J, Ravi BS, et al. Impact of pulmonary hypertension on the outcomes of non cardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol. 2005;45:1691–9.

    Article  PubMed  Google Scholar 

  2. Subramaniam K, Yared JP. Management of pulmonary hypertension in the operation room. Semin Cardiothorac Vasc Anesth. 2007;11:119–36.

    Article  PubMed  Google Scholar 

  3. Hosseinian L. Pulmonary hypertension and noncardiac surgery: implications for the anesthesiologists. J Cardiothorac Vasc Anesth. 2014;28:1076–86.

    Google Scholar 

  4. Vakil K, Duval S, Sharma A, et al. Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis. Int J Cardiol. 2014;176:595–9.

    Article  PubMed  Google Scholar 

  5. Galiè N, Hoeper MM, Humbert M, et al. ESC/ERS. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30:2493–537.

    Article  PubMed  Google Scholar 

  6. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit. State of the art and clinical and research implications. Circulation. 2009;120:992–1007.

    Article  PubMed  Google Scholar 

  7. Bossone E, Duong-Wagner TH, Paciocco G, et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr. 1999;12:655–62.

    Article  CAS  PubMed  Google Scholar 

  8. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.

    Article  PubMed  Google Scholar 

  9. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214–21.

    Article  CAS  PubMed  Google Scholar 

  10. Tuder RM, Cool CD, Geraci MW, et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med. 1999;159:1925–32.

    Article  CAS  PubMed  Google Scholar 

  11. Gaine S. Pulmonary hypertension. JAMA. 2000;284:3160–8.

    Article  CAS  PubMed  Google Scholar 

  12. Zamanian R, Haddad F, Doyle RL, et al. Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med. 2007;35:2037–50.

    Article  PubMed  Google Scholar 

  13. Mac Knight B, Martinez EA, Simon BA. Anesthetic management of patients with pulmonary hypertension. Semin Cardiothorac Vasc Anesth. 2008;12:91–6.

    Article  Google Scholar 

  14. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732–9.

    Article  CAS  PubMed  Google Scholar 

  15. Archer SL, Weir EK, Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation. 2010;121:2045–66.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43:25S–32.

    Article  PubMed  Google Scholar 

  17. Shah SJ. Pulmonary hypertension. JAMA. 2012;308:1366–74.

    Article  CAS  PubMed  Google Scholar 

  18. Fischer LG, Aken HV, Bürkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg. 2003;96:1603–16.

    Article  PubMed  Google Scholar 

  19. Minai OA, Yared JP, Kaw R, et al. Perioperative risk and management in patients with pulmonary hypertension. Chest. 2013;144:329–40.

    Article  PubMed  Google Scholar 

  20. Lai HC, Wang KY, Lee WL, et al. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth. 2007;99:184–90.

    Article  PubMed  Google Scholar 

  21. Price LC, Montani D, Jaïs X, et al. Noncardiothoracic non obstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J. 2010;35:1294–302.

    Article  CAS  PubMed  Google Scholar 

  22. Kaw R, Pasupuleti V, Deshpande A, et al. Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med. 2011;105:619–24.

    Article  PubMed  Google Scholar 

  23. Minai OA, Venkateshiah SB, Arroliga AC. Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med. 2006;70:239–43.

    PubMed  Google Scholar 

  24. Cesnjevar RA, Feyrer R, Walther F, et al. High-risk mitral valve replacement in severe pulmonary hypertension-30 years experience. Eur J Cardiothorac Surg. 1998;13:344–52.

    Article  CAS  PubMed  Google Scholar 

  25. Reich DL, Bodian CA, Krol M, et al. Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg. 1999;89:814–22.

    CAS  PubMed  Google Scholar 

  26. Melby SJ, Moon MR, Lindman BR, et al. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg. 2011;141:1424–30.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol. 2001;38:923–31.

    Article  CAS  PubMed  Google Scholar 

  28. Chang PP, Longenecker JC, Wang NY, et al. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant. 2005;24:998–1007.

    Article  PubMed  Google Scholar 

  29. Sztrymf B, Souza R, Bertoletti L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J. 2010;35:1286–93.

    Article  CAS  PubMed  Google Scholar 

  30. Forfia PR, Mathai SC, Fisher MR, et al. Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;177:1364–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Voelkel NF, Quaife RA, Leinwand LA. Right ventricular function and failure: report of a National Heart, Lung and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114:1883–91.

    Article  PubMed  Google Scholar 

  32. Bogaard HJ, Abe K, Vonk Noordegraaf A, et al. The right ventricle under pressure; cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest. 2009;135:794–804.

    Article  CAS  PubMed  Google Scholar 

  33. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577–95.

    CAS  PubMed  Google Scholar 

  34. Haddad F, Hunt SA, Rosenthal DN, et al. Right ventricular function in cardiovascular disease, Part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436–48.

    Article  PubMed  Google Scholar 

  35. Haddad F, Doyle R, Murphy DJ, et al. Right ventricular function in cardiovascular disease, Part II: Pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008;117:717–1731.

    Article  Google Scholar 

  36. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation. 1987;76:V52–5.

    Article  CAS  PubMed  Google Scholar 

  37. Kirklin JK, Naftel DC, Kirklin JW, et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 1988;7:331–6.

    CAS  PubMed  Google Scholar 

  38. Erickson KW, Costanzo-Nordin MR, O’Sullivan EJ, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Lung Transplant. 1990;9:526–37.

    CAS  Google Scholar 

  39. Chen JM, Levin HR, Michler RE, et al. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 1997;114:627–34.

    Article  CAS  PubMed  Google Scholar 

  40. Tenderich G, Koerner MM, Stuettgen B, et al. Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mmHg or >5 wood) predict early and long-term results after orthotopic heart transplantation? Transplant Proc. 1998;30:1130–1.

    Article  CAS  PubMed  Google Scholar 

  41. Espinoza NC, Manito N, Roca J, et al. Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: importance in the postoperative morbidity and mortality. Transplant Proc. 1999;31:2503–4.

    Article  CAS  PubMed  Google Scholar 

  42. Lindelow B, Andersson B, Waagstein F, et al. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. Eur Heart J. 1999;20:148–56.

    Article  CAS  PubMed  Google Scholar 

  43. Delgado JF, Gomez-Sanchez MA, Saenz C, et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pulse pressure profile after heart transplantation. J Heart Lung Transplant. 2001;20:942–8.

    Article  CAS  PubMed  Google Scholar 

  44. Cimato TR, Jessup M. Recipient selection in cardiac transplantation: contraindications and risk factors for mortality. J Heart Lung Transplant. 2002;21:1161–73.

    Article  PubMed  Google Scholar 

  45. Tsai FC, Marelli D, Bresson J, et al. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs. Am J Transplant. 2002;2:539–45.

    Article  PubMed  Google Scholar 

  46. Goland S, Czer LS, Kass RM, et al. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation. J Heart Lung Transplant. 2007;26:312–8.

    Article  PubMed  Google Scholar 

  47. Tenderich G, Koerner MM, Stuettgen B, et al. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation. J Cardiovasc Surg. 2000;41:215–9.

    CAS  Google Scholar 

  48. Klotz S, Wenzelburger F, Stypmann J, et al. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not transplant. Ann Thorac Surg. 2006;82:1770–3.

    Article  PubMed  Google Scholar 

  49. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant. 2006;25:1024–42.

    Article  PubMed  Google Scholar 

  50. Mancini D, Lietz K. Selection of cardiac trans-plantation candidates in 2010. Circulation. 2010;122(2):173–83.

    Article  PubMed  Google Scholar 

  51. Hosenpud JD, Bennett LE, Keck BM, et al. The Registry of the International Society for Heart and Lung Transplantion: seventeenth official report—2000. J Heart Lung Transplant. 2000;19:909–31.

    Article  CAS  PubMed  Google Scholar 

  52. Sitbon O, Humbert M, Jais X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005;111:3105–11.

    Article  CAS  PubMed  Google Scholar 

  53. Balzer DT, Kort HW, Day RW, et al. Inhaled nitric oxide as a preoperative test (INOP test I): the INOP Test Study Group. Circulation. 2002;106(12 suppl 1):176–81.

    Google Scholar 

  54. Berger S, Konduri GG. Pulmonary hypertension in children: the twenty first-century. Pediatr Clin North Am. 2006;53:961–87.

    Article  PubMed  Google Scholar 

  55. Kettner J, Dorazilova Z, Netuka I, et al. Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol Res. 2011;60:769–75.

    CAS  PubMed  Google Scholar 

  56. Zimpfer D, Zrunek P, Sandner S, et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg. 2007;31:698–702.

    Article  PubMed  Google Scholar 

  57. Etz C, Welp H, Tjan T, et al. Medically refractory pulmonary hypertension: treatment with non pulsatile left ventricular assist devices. Ann Thorac Surg. 2007;83:1697–706.

    Article  PubMed  Google Scholar 

  58. Punnoose L, Burkhoff D, Rich S, et al. Right ventricular assist device in end-stage pulmonary arterial hypertension: insights from a computational model of the cardiovascular system. Prog Cardiovasc Dis. 2012;55:234–43.

    Article  PubMed  Google Scholar 

  59. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report—2006. J Heart Lung Transplant. 2006;25:880–92.

    Article  PubMed  Google Scholar 

  60. Girgis RE, Theodore J. Physiology and function of the transplant lung allograft. In: Baumgartner WA, Reitz BA, Kasper E, et al., editors. Heart and lung transplantation. Philadelphia, PA: WB Saunders; 2002. p. 467–88.

    Google Scholar 

  61. Conte JV, Borja MJ, Patel CB, et al. Lung transplantation for primary and secondary pulmonary hypertension. Ann Thorac Surg. 2001;72:1673–9.

    Article  CAS  PubMed  Google Scholar 

  62. Kasimir MT, Seebacher G, Jaksch P, et al. Reverse cardiac remodeling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg. 2004;26:776–81.

    Article  PubMed  Google Scholar 

  63. Waddell TK, Bennett L, Kennedy R, et al. Heart-lung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21:731–7.

    Article  PubMed  Google Scholar 

  64. Santamore WP, Dell’Italia LJ. Ventricular interdependence: significant left ventricular contribution to right ventricular systolic function. Prog Cardiovasc Dis. 1998;40:289–308.

    Article  CAS  PubMed  Google Scholar 

  65. Lau CL, Patterson GA, Palmer SM. Critical care aspects of lung transplantation. J Intensive Care Med. 2004;19:83–104.

    Article  PubMed  Google Scholar 

  66. Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology. 2003;99:1415–32.

    Article  PubMed  Google Scholar 

  67. Gayes JM, Giron L, Nissen MD, et al. Anesthetic considerations for patients undergoing double-lung transplantation. J Cardiothorac Anesth. 1990;4:486–98.

    Article  CAS  PubMed  Google Scholar 

  68. Hohn L, Schweizer A, Morel DR, et al. Circulatory failure after anesthesia induction in a patient with severe primary pulmonary hypertension. Anesthesiology. 1999;91:1943–5.

    Article  CAS  PubMed  Google Scholar 

  69. Piazza G, Goldhaber SZ. The acutely decompensated right ventricle: pathways for diagnosis and management. Chest. 2005;128:1836–52.

    Article  PubMed  Google Scholar 

  70. van Wolferen SA, Marcus JT, Westerhof N, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J. 2008;29:120–7.

    Article  PubMed  Google Scholar 

  71. de Boer W, Waterbolk TW, Brugemann J, et al. Extracorporeal membrane oxygenation before induction of anesthesia in critically ill thoracic transplant patients. Ann Thorac Surg. 2001;72:1407–8.

    Article  PubMed  Google Scholar 

  72. Cannesson M, Earing MG, Collange V, et al. Anesthesia for non cardiac surgery in adults with congenital heart disease. Anesthesiology. 2009;111:432–40.

    Article  PubMed  Google Scholar 

  73. Ebert TJ, Muzi M, Berens R, et al. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992;76:725–33.

    Article  CAS  PubMed  Google Scholar 

  74. Sarkar M, Laussen PC, Zurakowski D, et al. Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients. Anesth Analg. 2005;101:645–50.

    Article  CAS  PubMed  Google Scholar 

  75. Todd MM, Drummond JC, U HS. The hemodynamic consequences of high-dose thiopental anesthesia. Anesth Analg. 1985;64:681–7.

    Article  CAS  PubMed  Google Scholar 

  76. Strumpher J, Jacobsohn E. Pulmonary hypertension and right ventricular dysfunction: physiology and perioperative management. J Cardiothorac Vasc Anesth. 2011;25:687–704.

    Article  PubMed  Google Scholar 

  77. Morray JP, Lynn AM, Stamm SJ, et al. Hemodynamic effects of ketamine in children with congenital heart disease. Anesth Analg. 1984;63:895–9.

    CAS  PubMed  Google Scholar 

  78. Williams GD, Philip BM, Chu LF, et al. Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation. Anesth Analg. 2007;105:1578–84.

    Article  CAS  PubMed  Google Scholar 

  79. Kaye AD, Hoover JM, Kaye AJ, et al. Morphine, opioids, and the feline pulmonary vascular bed. Acta Anaesthesiol Scand. 2008;52:931–7.

    Article  CAS  PubMed  Google Scholar 

  80. Kerbaul F, Rondelet B, Motte S, et al. Isoflurane and desflurane impair right ventricular-pulmonary arterial coupling in dogs. Anesthesiology. 2004;101:1357–62.

    Article  CAS  PubMed  Google Scholar 

  81. Kerbaul F, Bellezza M, Mekkaoui C, et al. Sevoflurane alters right ventricular performance but not pulmonary vascular resistance in acutely instrumented anesthetized pigs. J Cardiothorac Vasc Anesth. 2006;20:209–16.

    Article  PubMed  Google Scholar 

  82. Keogh AM, Mayer E, Benza RL, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol. 2009;54:S67–77.

    Article  PubMed  Google Scholar 

  83. Nishikawa T, Dohi S. Errors in the measurement of cardiac output by thermodilution. Can J Anaesth. 1993;40:142–53.

    Article  CAS  PubMed  Google Scholar 

  84. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–52.

    Article  PubMed  Google Scholar 

  85. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818–27.

    Article  PubMed  Google Scholar 

  86. Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354:2213–24.

    Article  PubMed  Google Scholar 

  87. Rudolph AM, Yuan S. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. J Clin Invest. 1966;45:399–411.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. McIntyre KM, Sasahara AA. Determinants of right ventricular function and hemodynamics after pulmonary embolism. Chest. 1974;65:534–43.

    Article  CAS  PubMed  Google Scholar 

  89. Goldstein JA, Barzilai B, Rosamond TL, et al. Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation. 1990;82:359–68.

    Article  CAS  PubMed  Google Scholar 

  90. Meluzin J, Spiranova L, Bakala J. Pulsed Doppler. Tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid and non-invasive method of evaluating right ventricular systolic function. Eur Heart J. 2001;22:340–8.

    Article  CAS  PubMed  Google Scholar 

  91. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med. 2006;174:1034–41.

    Article  PubMed  Google Scholar 

  92. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009;179:615–21.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Hammarstrom E, Wranne B, Pinto FJ, et al. Tricuspid annular motion. J Am Soc Echocardiogr. 1991;4:131–9.

    Article  CAS  PubMed  Google Scholar 

  94. Jardin F, Vieillard-Baron A. Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings. Intensive Care Med. 2003;29:1426–34.

    Article  PubMed  Google Scholar 

  95. Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome? Curr Opin Crit Care. 2003;9:15–21.

    Article  PubMed  Google Scholar 

  96. Pritts CD, Pearl RG. Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol. 2010;23:411–6.

    Article  PubMed  Google Scholar 

  97. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–8.

    Article  Google Scholar 

  98. Ko WJ, Chen YS, Lee YC. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Artif Organs. 2001;25:607–12.

    Article  CAS  PubMed  Google Scholar 

  99. Raffin L, Michel-Cherqui M, Sperandio M, et al. Anesthesia for bilateral lung transplantation without cardiopulmonary bypass: initial experience and review of intraoperative problems. J Cardiothorac Vasc Anesth. 1992;6:409–17.

    Article  CAS  PubMed  Google Scholar 

  100. Aeba R, Griffith BP, Kormos RL, et al. Effect of cardiopulmonary bypass on early graft dysfunction in clinical lung transplantation. Ann Thorac Surg. 1994;57:715–22.

    Article  CAS  PubMed  Google Scholar 

  101. Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part IV: Recipient-related risk factors and markers. J Heart Lung Transplant. 2005;24:1468–82.

    Article  PubMed  Google Scholar 

  102. Christie JD, Carby M, Bag R, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction: part II. Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–9.

    Article  PubMed  Google Scholar 

  103. Whitson BA, Nath DS, Johnson AC, et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2006;131:73–80.

    Article  PubMed  Google Scholar 

  104. de Perrot M, Bonser RS, Dark J, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Donor-related risk factors and markers. J Heart Lung Transplant. 2005;24:1460–7.

    Article  PubMed  Google Scholar 

  105. Hartwig MG, Appel III JZ, Cantu III E, et al. Improved results treating lung allograft failure with venovenous extracorporeal membrane oxygenation. Ann Thorac Surg. 2005;80:1872–9.

    Article  PubMed  Google Scholar 

  106. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg. 2007;31:468–73.

    Article  PubMed  Google Scholar 

  107. Missant C, Rex S, Claus P, et al. Thoracic epidural anesthesia disrupts the protective mechanism of homeometric autoregulation during right ventricular pressure overload by cardiac sympathetic blockade: a randomized controlled animal study. Eur J Anaesthesiol. 2011;28:535–43.

    Article  PubMed  Google Scholar 

  108. Nygård E, Kofoed KF, Freiberg J, et al. Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease. Circulation. 2005;111:2165–70.

    Article  PubMed  CAS  Google Scholar 

  109. Veering BT, Cousins MJ. Cardiovascular and pulmonary effects of epidural anaesthesia. Anaesth Intensive Care. 2000;28:620–35.

    CAS  PubMed  Google Scholar 

  110. Von Dossow V, Welte M, Zaune U, et al. Thoracic epidural anesthesia combined with general anesthesia: the preferred anesthetic technique for thoracic surgery. Anesth Analg. 2001;92:848–54.

    Article  Google Scholar 

  111. Pollard JB. Common mechanisms and strategies for prevention and treatment of cardiac arrest during epidural anesthesia. J Clin Anesth. 2002;14:52–6.

    Article  PubMed  Google Scholar 

  112. Mishra L, Pani N, Samantaray R, Nayak K. Eisenmenger’s syndrome in pregnancy: use of epidural anesthesia and analgesia for elective cesarean section. J Anaesthesiol Clin Pharmacol. 2014;30(3):425–6.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Hasegawa A, Azuma Y, Ohashi Y, Yamashina M, Moriyama K, Iijima T, Yorozu T. [Anesthetic management of a patient with pulmonary arterial hypertension undergoing caesarean section]. Masui. 2013;62(2):183–5.

    PubMed  Google Scholar 

  114. Bonnin M, Mercier FJ, Sitbon O, Roger-Christoph S, Jaïs X, Humbert M, Audibert F, Frydman R, Simonneau G, Benhamou D. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology. 2005;102(6):1133–7. discussion 5A–6A.

    Article  PubMed  Google Scholar 

  115. Khan MJ, Bhatt SB, Kryc JJ. Anesthetic considerations for parturients with primary pulmonary hypertension: review of the literature and clinical presentation. Int J Obstet Anesth. 1996;5(1):36–42.

    Article  CAS  PubMed  Google Scholar 

  116. Atanassoff P, Alon E, Schmid ER, Pasch T. Epidural anesthesia for cesarean section in a patient with severe pulmonary hypertension. Acta Anaesthesiol Scand. 1990;34(1):75–7.

    Article  CAS  PubMed  Google Scholar 

  117. Davies MJ, Beavis RE. Epidural anaesthesia for vascular surgery in a patient with primary pulmonary hypertension. Anaesth Intensive Care. 1984;12(2):165–7.

    CAS  PubMed  Google Scholar 

  118. Armstrong P. Thoracic epidural anaesthesia and primary pulmonary hypertension. Anaesthesia. 1992;47(6):496–9.

    Article  CAS  PubMed  Google Scholar 

  119. Chakravarthy M, Jawali V, Patil T, Krishnamoorthy J. Decrease in pulmonary artery pressure after administration of thoracic epidural anesthesia in a patient with Marfan syndrome awaiting aortic valve replacement procedure. J Clin Monit Comput. 2011;25(4):265–8.

    Article  PubMed  Google Scholar 

  120. Subash G, Mohammed S. Perioperative cardiac arrest after thoracic epidural analgesia in a patient with increased pulmonary artery pressure. Br J Anaesth. 2011;107(1):108–9.

    Article  CAS  PubMed  Google Scholar 

  121. Mallampati SR. Low thoracic epidural anaesthesia for elective cholecystectomy in a patient with congenital heart disease and pulmonary hypertension. Can Anaesth Soc J. 1983;30(1):72–6.

    Article  CAS  PubMed  Google Scholar 

  122. Burrows FA. Epidural anaesthesia and pulmonary hypertension. Can Anaesth Soc J. 1983;30(4):445–6.

    Article  CAS  PubMed  Google Scholar 

  123. Friesen RH, Williams GD. Anesthetic management of children with pulmonary arterial hypertension. Pediatr Anaesth. 2008;18:208–16.

    Article  Google Scholar 

  124. Lang G, Klepetko W. Lung transplantation for end-stage primary pulmonary hypertension. Ann Transplant. 2004;9:25–32.

    Article  CAS  PubMed  Google Scholar 

  125. Kwak YL, Lee CS, Park YH, et al. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension. Anaesthesia. 2002;57:9–14.

    Article  CAS  PubMed  Google Scholar 

  126. Leather HA, Segers P, Berends N, et al. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med. 2002;30:2548–52.

    Article  CAS  PubMed  Google Scholar 

  127. Price LC, Wort SJ, Finney SJ, et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit Care. 2010;14:R169.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Chen EP, Bittner HB, Davis Jr RD, et al. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg. 1997;63:814–21.

    Article  CAS  PubMed  Google Scholar 

  129. Wang H, Gong M, Zhou B, et al. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery. Adv Ther. 2009;26:462–8.

    Article  CAS  PubMed  Google Scholar 

  130. Sablotzki A, Startzmann W, Scheubel R, et al. Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidates. Can J Anaesth. 2005;52:1076–82.

    Article  PubMed  Google Scholar 

  131. Lamarche Y, Perrault LP, Maltais S, et al. Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg. 2007;31:1081–7.

    Article  PubMed  Google Scholar 

  132. Lamarche Y, Malo M, Thorin E, et al. Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;130:83–92.

    Article  CAS  PubMed  Google Scholar 

  133. Laflamme M, Perrault LP, Carrier M, Elmi-Sarabi M, Fortier A, Denault AY. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension. J Cardiothorac Vasc Anesth. 2015;29(1):38–45.

    Article  CAS  PubMed  Google Scholar 

  134. Kerbaul F, Rondelet B, Motte S. Effects of norepinephrine and Dobutamine on pressure-load induced right ventricular failure. Crit Care Med. 2004;32:1035–40.

    Article  CAS  PubMed  Google Scholar 

  135. Kota B, Prasad AS, Economides C, et al. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure. J Cardiovasc Pharmacol Ther. 2008;13:269–78.

    Article  CAS  PubMed  Google Scholar 

  136. Parissis JT, Karavidas A, Bistola V. Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure. Atherosclerosis. 2008;197:278–82.

    Article  CAS  PubMed  Google Scholar 

  137. Kerbaul F, Rondelet B, Demester JP, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med. 2006;34:2814–9.

    Article  CAS  PubMed  Google Scholar 

  138. Morelli A, Teboul JL, Maggiore SM. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med. 2006;34:2287–93.

    Article  CAS  PubMed  Google Scholar 

  139. Kopustinskiene DM, Pollesello P, Saris NE. Levosimendan is a mitochondrial K(ATP) channel opener. Eur J Pharmacol. 2001;428:311–4.

    Article  CAS  PubMed  Google Scholar 

  140. Gruhn N, Nielsen-Kudsk JE, Theilgarrd S, et al. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol. 1998;31:741–9.

    Article  CAS  PubMed  Google Scholar 

  141. Jeon Y, Ryu JH, Lim YJ, et al. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg. 2006;29:952–6.

    Article  PubMed  Google Scholar 

  142. Salzberg SP, Filsoufi F, Anyanwu A, et al. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg. 2005;80:502–6.

    Article  PubMed  Google Scholar 

  143. Kelesidis I, Mazurek JA, Saeed W, et al. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension. Congest Heart Fail. 2012;18:8–24.

    Google Scholar 

  144. Galiè N, Ghofrani HA, Torbicki A, et al. Slidenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–57.

    Article  PubMed  Google Scholar 

  145. Galiè N, Brundage BH, Ghofrani HA, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009;119:2894–903.

    Article  PubMed  CAS  Google Scholar 

  146. Bigatello LM, Hess D, Dennehy KC, et al. Sildenafil can increase the response to nitric oxide. Anesthesiology. 2000;92:1827–9.

    Article  CAS  PubMed  Google Scholar 

  147. Steiner MK, Preston IR, Klinger JR, et al. Pulmonary hypertension: inhaled nitric oxide, Sildenafil and natriuretic peptides. Curr Opin Pharmacol. 2005;5:245–50.

    Article  CAS  PubMed  Google Scholar 

  148. Lepore JJ, Maroo A, Bigatello LM, et al. Hemodynamic effects of Sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest. 2005;127:1647–53.

    Article  CAS  PubMed  Google Scholar 

  149. Vachiery JL, Huez S, Gillies H, et al. Safety, tolerability and pharmacokinetics of an intravenous bolus of slidenafil in patients with pulmonary arterial hypertension. Br J Clin Pharmacol. 2011;71:289–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  150. Atz AM, Wessel DL. Sildenafil ameliorates effect of inhaled nitric oxide withdrawal. Anesthesiology. 1999;91:307–10.

    Article  CAS  PubMed  Google Scholar 

  151. Lee JE, Hillier SC, Knoderer CA. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease. J Intensive Care Med. 2008;23:329–34.

    Article  PubMed  Google Scholar 

  152. De Santo LS, Mastroianni C, Romano G, et al. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients. Transplant Proc. 2008;40:2015–8.

    Article  PubMed  CAS  Google Scholar 

  153. Lahm T, McCaslin CA, Wozniak TC, et al. Medical and surgical treatment of acute right ventricular failure. J Am Coll Cardiol. 2010;56:1435–46.

    Article  PubMed  Google Scholar 

  154. Inglessis I, Shin JT, Lepore JJ, et al. Hemodynamic effects of inhaled nitric oxide in right ventricular infarction and cardiogenic shock. J Am Coll Cardiol. 2004;44:793–8.

    Article  CAS  PubMed  Google Scholar 

  155. Fujita Y, Nishida O, Sobue K, et al. Nitric oxide inhalation is useful in the management of right ventricular failure caused by myocardial infarction. Crit Care Med. 2002;30:1379–81.

    Article  CAS  PubMed  Google Scholar 

  156. Oz MC, Ardehali A. Collective review: perioperative uses of inhaled nitric oxide in adults. Heart Surg Forum. 2004;7:E584–9.

    Article  PubMed  Google Scholar 

  157. Rimar S, Gillis CN. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation. 1993;88:2884–7.

    Article  CAS  PubMed  Google Scholar 

  158. Vizza CD, Rocca GD, Roma AD, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care. 2001;5:355–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Bradford KK, Deb B, Pearl RG. Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit. J Cardiovasc Pharmacol. 2000;36:146–51.

    Article  CAS  PubMed  Google Scholar 

  160. George I, Xydas S, Topkara VK, et al. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg. 2006;82:2161–9.

    Article  PubMed  Google Scholar 

  161. Bocchi EA, Bacal F, Costa Auler Junior JO, et al. Inhaled nitric oxide leading to pulmonary edema in stable severe heart failure. Am J Cardiol. 1994;74:70–2.

    Article  CAS  PubMed  Google Scholar 

  162. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol. 1994;24:982–8.

    Article  CAS  PubMed  Google Scholar 

  163. Christenson J, Lavoie A, O’Conner M, et al. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med. 2000;161:1443–9.

    Article  CAS  PubMed  Google Scholar 

  164. Adhikari NK, Burns KE, Friedrich JO, et al. Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ. 2007;334:779.

    Article  PubMed  PubMed Central  Google Scholar 

  165. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med. 1996;334:296–302.

    Article  CAS  PubMed  Google Scholar 

  166. Olschewski H, Simonneau G, Galiè N, et al. Inhaled iloprost in severe pulmonary hypertension. N Engl J Med. 2002;347:322–9.

    Article  CAS  PubMed  Google Scholar 

  167. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, et al. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest. 1998;114:780–6.

    Article  CAS  PubMed  Google Scholar 

  168. Khan TA, Schnickel G, Ross D, et al. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg. 2009;138:1417–24.

    Article  CAS  PubMed  Google Scholar 

  169. Voswinckle R, Enke B, Reichenberger F, et al. Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies. J Am Coll Cardiol. 2006;48:1672–81.

    Article  CAS  Google Scholar 

  170. Le Varge BL, Channick RN. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. Expert Rev Respir Med. 2012;6:255–65.

    Article  CAS  Google Scholar 

  171. Huang J, Bouvette MJ, Zhou J. Simultaneous delivery of inhaled prostacyclin and milrinone through a double nebulizer system. J Cardiothorac Vasc Anesth. 2011;25:590–1.

    Article  CAS  PubMed  Google Scholar 

  172. Galiè N, Olschewski H, Oudiz RJ, et al. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double blind, placebo controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation. 2008;117:3010–9.

    Article  PubMed  CAS  Google Scholar 

  173. Gille J, Seyfarth HJ, Gerlach S, Malcharek M, Czeslick E, Sablotzki A. Perioperative anesthesiological management of patients with pulmonary hypertension. Anesthesiol Res Pract. 2012;2012:356982.

    PubMed  PubMed Central  Google Scholar 

  174. Liu H, Kalarickal PL, Tong Y, et al. Perioperative considerations of patients with pulmonary hypertension. In: Elwing JM, Panos RJ, editors. Pulmonary hypertension [Internet]. Rijeka, Croatia: InTech; 2013 [cited 2015 Jul 22]. Available from: http://www.intechopen.com/books/pulmonary-hypertension/perioperative-considerations-of-patients-with-pulmonary-hypertension. doi:10.5772/56056

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Soheyla Nazarnia M.D.

Authors
  1. Soheyla Nazarnia M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Soheyla Nazarnia M.D. .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA

    Kathirvel Subramaniam

  2. Department of Anesthesiology The Clinical and Translational Science Institute The McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Tetsuro Sakai

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Nazarnia, S. (2017). Perioperative Management of Pulmonary Hypertension. In: Subramaniam, K., Sakai, T. (eds) Anesthesia and Perioperative Care for Organ Transplantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6377-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6377-5_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-6375-1

  • Online ISBN: 978-1-4939-6377-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation